SBX.XETRA SynBiotic SE

Healthcare Pharmaceuticals XETRA Stock Exchange
0.1400 EUR
Close of Nov 6, 2026
0.1020 3.85
Market cap
EUR 1.02M
P/E
-
P/B
0.17x
ROE
-42.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is SBX.XETRA undervalued?

Graham number

The Graham number of SynBiotic SE cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SynBiotic SE fundamental analysis

No fundamental analysis for SynBiotic SE yet.

SynBiotic SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SynBiotic SE

SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.

Full company profile